Skip to content

Repligen

US · RGEN #1445 by market cap Listed 1970
167.22 -7.64 -4.37%
Live - 5344 symbols - heartbeat 196s ago · 2026-10-08 08:13
Pre-market 165.69 -0.91%
After-hours 167.22 0.00%
Overnight 166.83 -0.23%
Market cap
10.62B
P/B
5.03
EPS
0.86
Reader sentiment Are you bullish or bearish on RGEN?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • Rating change
    Evercore Maintains Repligen(RGEN.US) With Buy Rating, Raises Target Price to $160
    Market Newswire · 2026/7/6
  • Rating change
    A Quick Look at Today's Ratings for Repligen(RGEN.US), With a Forecast Between $142 to $200
    Market Newswire · 2026/5/6
  • Rating change
    CCORF Maintains Repligen(RGEN.US) With Hold Rating, Cuts Target Price to $145
    Market Newswire · 2026/4/20
  • Rating change
    Craig-Hallum Maintains Repligen(RGEN.US) With Buy Rating, Announces Target Price $204
    Market Newswire · 2026/5/6
  • Stifel Maintains Repligen(RGEN.US) With Buy Rating, Maintains Target Price $207
    Market Newswire · 2026/7/30
  • Rating change
    Wells Fargo Maintains Repligen(RGEN.US) With Buy Rating, Raises Target Price to $185
    Market Newswire · 2026/7/30
  • Rating change
    RBC Capital Maintains Repligen(RGEN.US) With Buy Rating, Maintains Target Price $160
    Market Newswire · 2026/7/24
  • Rating change
    J.P. Morgan Maintains Repligen(RGEN.US) With Buy Rating, Cuts Target Price to $165
    Market Newswire · 2026/5/6
  • Wells Fargo Initiates Repligen(RGEN.US) With Buy Rating, Announces Target Price $185
    Market Newswire · 2026/8/17
  • Rating change
    William Blair Maintains Repligen(RGEN.US) With Buy Rating
    Market Newswire · 2026/7/22
  • Rating change
    UBS Maintains Repligen(RGEN.US) With Buy Rating, Cuts Target Price to $160
    Market Newswire · 2026/5/15
  • Rating change
    J.P. Morgan Maintains Repligen(RGEN.US) With Buy Rating, Raises Target Price to $175
    Market Newswire · 2026/7/29
  • Barclays Maintains Repligen(RGEN.US) With Buy Rating, Maintains Target Price $160
    Market Newswire · 2026/7/23
  • Rating change
    A Quick Look at Today's Ratings for Repligen(RGEN.US), With a Forecast Between $175 to $200
    Market Newswire · 2026/7/29
  • Rating change
    Wolfe Research Initiates Repligen(RGEN.US) With Buy Rating, Announces Target Price $145
    Market Newswire · 2026/6/2
  • Rating change
    Craig-Hallum Maintains Repligen(RGEN.US) With Buy Rating
    Market Newswire · 2026/6/25
  • Stifel Maintains Repligen(RGEN.US) With Buy Rating
    Market Newswire · 2026/9/16
  • UBS Maintains Repligen(RGEN.US) With Buy Rating, Maintains Target Price $225
    Market Newswire · 2026/9/29
  • Rating change
    Benchmark Co. Upgrades Repligen(RGEN.US) to Buy Rating, Announces Target Price $185
    Market Newswire · 2026/7/7
  • Rating change
    CCORF Maintains Repligen(RGEN.US) With Hold Rating, Maintains Target Price $145
    Market Newswire · 2026/7/29

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-08 08:13:50 · For reference only, not investment advice and not tailored to your situation.